Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seroprevalence of COVID-19 in Niger State

View ORCID ProfileH. Majiya, M. Aliyu-Paiko, V.T. Balogu, D.A. Musa, I.M. Salihu, A.A. Kawu, Y.I. Bashir, R.A. Sani, J. Baba, A.T. Muhammad, F.L. Jibril, E. Bala, N.G. Obaje, B.Y. Aliyu, R.G. Muhammad, H. Mohammed, N.U. Gimba, A. Uthman, H.M. Liman, A.A. Sule, K.J. Joseph, M.M. Makusidi, M.D. Isah, I. Abdullahi, U. Ndagi, B. Waziri, C.I. Bisallah, N.J. Dadi-Mamud, K. Ibrahim, A.K. Adamu
doi: https://doi.org/10.1101/2020.08.04.20168112
H. Majiya
1Department of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
7Center for Applied Sciences and Technology Research, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H. Majiya
  • For correspondence: husssainimajiya@ibbul.edu.ng
M. Aliyu-Paiko
2Department of Biochemistry, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V.T. Balogu
1Department of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.A. Musa
2Department of Biochemistry, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I.M. Salihu
3Department of Biology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.A. Kawu
4Department of Computer Science, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y.I. Bashir
5Department of Geography, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.A. Sani
1Department of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Baba
1Department of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.T. Muhammad
6Department of Mathematics, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F.L. Jibril
1Department of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Bala
1Department of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N.G. Obaje
7Center for Applied Sciences and Technology Research, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B.Y. Aliyu
6Department of Mathematics, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.G. Muhammad
1Department of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Mohammed
2Department of Biochemistry, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N.U. Gimba
3Department of Biology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Uthman
2Department of Biochemistry, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.M. Liman
5Department of Geography, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.A. Sule
8General Hospital, Minna, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K.J. Joseph
9Niger State Ministry of Health, Minna, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.M. Makusidi
9Niger State Ministry of Health, Minna, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.D. Isah
8General Hospital, Minna, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Abdullahi
4Department of Computer Science, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
U. Ndagi
10IBB Specialised Hospital, Minna, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Waziri
10IBB Specialised Hospital, Minna, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.I. Bisallah
1Department of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N.J. Dadi-Mamud
3Department of Biology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Ibrahim
1Department of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.K. Adamu
3Department of Biology, Ibrahim Badamasi Babangida University, Lapai, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Coronavirus Disease 2019 (COVID-19) Pandemic is ongoing, and to know how far the virus has spread in Niger State, Nigeria, a pilot study was carried out to determine the COVID-19 seroprevalence, patterns, dynamics, and risk factors in the state. A cross sectional study design and clustered-stratified-Random sampling strategy were used. COVID-19 IgG and IgM Rapid Test Kits (Colloidal gold immunochromatography lateral flow system) were used to determine the presence or absence of antibodies to SARS-CoV-2 in the blood of sampled participants across Niger State as from 26th June 2020 to 30th June 2020. The test kits were validated using the blood samples of some of the NCDC confirmed positive and negative COVID-19 cases in the State. COVID-19 IgG and IgM Test results were entered into the EPIINFO questionnaire administered simultaneously with each test. EPIINFO was then used for both the descriptive and inferential statistical analyses of the data generated. The seroprevalence of COVID-19 in Niger State was found to be 25.41% and 2.16% for the positive IgG and IgM respectively. Seroprevalence among age groups, gender and by occupation varied widely. A seroprevalence of 37.21% was recorded among health care workers in Niger State. Among age groups, COVID-19 seroprevalence was found to be in order of 30-41 years (33.33%) > 42-53 years (32.42%) > 54-65 years (30%) > 66 years and above (25%) > 6-17 years (19.20%) > 18-29 years (17.65%) > 5 years and below (6.66%). A seroprevalence of 27.18% was recorded for males and 23.17% for females in the state. COVID-19 asymptomatic rate in the state was found to be 46.81%. The risk analyses showed that the chances of infection are almost the same for both urban and rural dwellers in the state. However, health care workers and those that have had contact with person (s) that travelled out of Nigeria in the last six (6) months are twice (2 times) at risk of being infected with the virus. More than half (54.59%) of the participants in this study did not practice social distancing at any time since the pandemic started. Discussions about knowledge, practice and attitude of the participants are included. The observed Niger State COVID-19 seroprevalence means that the herd immunity for COVID-19 is yet to be achieved and the population is still susceptible for more infection and transmission of the virus. If the prevalence stays as reported here, the population will definitely need COVID-19 vaccines when they become available. Niger State should fully enforce the use of face/nose masks and observation of social/physical distancing in gatherings including religious gatherings in order to stop or slow the spread of the virus.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the Ibrahim Badamasi Babangida University, Lapai, Niger State, Nigeria.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research Ethics Committee, Niger Sate Ministry of Health, Minna, Nigeria

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data referred to in the manuscript are available

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted August 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Seroprevalence of COVID-19 in Niger State
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Seroprevalence of COVID-19 in Niger State
H. Majiya, M. Aliyu-Paiko, V.T. Balogu, D.A. Musa, I.M. Salihu, A.A. Kawu, Y.I. Bashir, R.A. Sani, J. Baba, A.T. Muhammad, F.L. Jibril, E. Bala, N.G. Obaje, B.Y. Aliyu, R.G. Muhammad, H. Mohammed, N.U. Gimba, A. Uthman, H.M. Liman, A.A. Sule, K.J. Joseph, M.M. Makusidi, M.D. Isah, I. Abdullahi, U. Ndagi, B. Waziri, C.I. Bisallah, N.J. Dadi-Mamud, K. Ibrahim, A.K. Adamu
medRxiv 2020.08.04.20168112; doi: https://doi.org/10.1101/2020.08.04.20168112
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Seroprevalence of COVID-19 in Niger State
H. Majiya, M. Aliyu-Paiko, V.T. Balogu, D.A. Musa, I.M. Salihu, A.A. Kawu, Y.I. Bashir, R.A. Sani, J. Baba, A.T. Muhammad, F.L. Jibril, E. Bala, N.G. Obaje, B.Y. Aliyu, R.G. Muhammad, H. Mohammed, N.U. Gimba, A. Uthman, H.M. Liman, A.A. Sule, K.J. Joseph, M.M. Makusidi, M.D. Isah, I. Abdullahi, U. Ndagi, B. Waziri, C.I. Bisallah, N.J. Dadi-Mamud, K. Ibrahim, A.K. Adamu
medRxiv 2020.08.04.20168112; doi: https://doi.org/10.1101/2020.08.04.20168112

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (139)
  • Cardiovascular Medicine (1944)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (698)
  • Epidemiology (11100)
  • Forensic Medicine (8)
  • Gastroenterology (623)
  • Genetic and Genomic Medicine (3164)
  • Geriatric Medicine (308)
  • Health Economics (561)
  • Health Informatics (2042)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12717)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2985)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1550)
  • Ophthalmology (477)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2782)
  • Public and Global Health (5590)
  • Radiology and Imaging (1093)
  • Rehabilitation Medicine and Physical Therapy (632)
  • Respiratory Medicine (759)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)